TRDA Entrada Therapeutics PE ratio, current and historical analysis
As at Nov 21, 2024, the TRDA stock has a PE ratio of 10.81. This is based on the current EPS of $1.67 and the stock price of $18.05 per share.
TRDA PE ratio history
The mean historical PE ratio of Entrada Therapeutics over the last three years is 7.62. The current 10.81 price-to-earnings ratio is 42% more than the historical average. In the past three years, TRDA's PE ratio reached its highest point in the Mar 2024 quarter at 20.24, with a price of $14.17 and an EPS of $0.7. The Sep 2022 quarter saw the lowest point at 1.14, with a price of $15.76 and an EPS of $13.79.
Entrada Therapeutics PE ratio by year
| Year | PE ratio | Change |
|---|---|---|
| 2023 | N/A | N/A |
| 2022 | N/A | N/A |
| 2021 | N/A | N/A |
| 2020 | N/A | N/A |
| 2019 | N/A | N/A |
TRDA average PE ratio chart
The current PE ratio of TRDA is above its 3-year historical average.
TRDA PE vs peers
TRDA's PE ratio is below its peer stocks AMGN and GILD.
| Stock name | PE ratio | Market cap |
|---|---|---|
| TRDA Entrada Therapeutics Inc | 10.81 | $675.43M |
| BIIB Biogen Inc | 14.22 | $23.03B |
| REGN Regeneron Pharmaceuticals Inc | 17.22 | $81.81B |
| AMGN Amgen Inc | 36.74 | $155.83B |
| GILD Gilead Sciences Inc | 897.6 | $111.86B |
| VRTX Vertex Pharmaceuticals Inc | N/A | $115.98B |
| NTLA Intellia Therapeutics Inc | N/A | $1.41B |
| MRNA Moderna Inc | N/A | $14.72B |
| CRSP CRISPR Therapeutics AG | N/A | $3.95B |
| EDIT Editas Medicine Inc | N/A | $195.64M |
Frequently asked questions
What is Entrada Therapeutics's PE ratio?
TRDA stock has a price to earnings ratio of 10.81 as of Nov 21, 2024.
What is the 3-year average PE ratio for Entrada Therapeutics (TRDA)?
As an average over the last 3 years, TRDA stock has a PE ratio of 7.62.
What is the highest PE ratio for TRDA?
In the last three years, the Mar 2024 quarter recorded the highest quarterly PE ratio at 20.24.
How does the current PE ratio for TRDA compare to its historical average?
TRDA's current price to earnings ratio is 42% above its 3-year historical average.
How is TRDA's PE ratio calculated (Entrada Therapeutics PE ratio formula)?
You can calculate the P/E ratio by dividing the most recent stock price by the trailing twelve months earnings per share(EPS). As of today (Nov 21, 2024), Entrada Therapeutics's stock price is $18.05. The earnings per share for the trailing twelve months (TTM) ending Sep 2024 is $1.67. Therefore, Entrada Therapeutics's price to earnings ratio for today is 10.81. PE RATIO(10.81) = STOCK PRICE($18.05) / TTM EPS($1.67)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified. Data from 
and Sharadar.